603896.SS - Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Shanghai - Shanghai Delayed price. Currency in CNY
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
795,043
829,072
767,137
636,051
546,759
Cost of revenue
119,762
129,207
126,373
105,672
85,407
Gross profit
675,281
699,864
640,765
530,379
461,352
Operating expenses
Research development
53,661
47,824
50,825
48,485
39,419
Selling general and administrative
355,846
356,565
355,429
309,012
292,630
Total operating expenses
432,660
432,505
440,809
374,181
347,367
Operating income or loss
242,621
267,359
199,956
156,198
113,985
Interest expense
9,054
13,028
10,170
11,716
978.9927
Income before tax
244,241
277,966
201,061
153,702
124,994
Income tax expense
455.9957
452.5683
749.2865
1,990
1,099
Income from continuing operations
243,785
277,513
200,311
151,712
123,895
Net income
243,911
277,783
200,827
151,712
123,895
Net income available to common shareholders
243,911
277,783
200,827
151,712
123,895
Basic EPS
-
-
1.05
0.82
0.68
Diluted EPS
-
-
1.05
0.82
0.68
Basic average shares
-
-
191,263
184,323
183,027
Diluted average shares
-
-
191,263
184,323
183,027
EBITDA
-
355,371
265,128
208,753
167,012